Coherus Oncology · 3 months ago
Executive Director, Medical Communications
Redwood City, CA
Full-time
Onsite
Director/Executive
$250K/yr - $290K/yr
12+ years expCoherus BioSciences is a biopharmaceutical company focused on immuno-oncology and biosimilar products. They are seeking an Executive Director of Medical Communications to provide strategic leadership and manage scientific communication activities, ensuring high-quality deliverables that align with medical objectives.
BiotechnologyHealth CareMedicalOncologyTherapeutics
Responsibilities
Become a subject matter expert and internal liaison for immuno-oncology and other pipeline products
Accountable/responsible for all aspects of scientific communications including publications, scientific platform/scientific statement development, congress communications, and field medical content development for immune-oncology and other pipeline products
Oversee the development and tactical execution of a cross-functional strategic publication plan for each approved and pipeline product and contribute to the Medical Affairs plan (approved products)
Demonstrate deep, extensive knowledge and understanding of the disease area, medical strategies, and objectives necessary to provide strategic input to a broad range of stakeholders on matters related to publication planning & data dissemination/disclosure
Develop and refine publication strategic objectives for the assigned assets aligned with the overall medical objectives, participation in data analysis efforts, editing and preparation of publications for submission, while ensuring adherence to policies and procedures established by Coherus, journals, and ICMJE
Responsible for the development of scientific content and slides for the field medical team/Medical Science Liaison team, aligned with overall scientific narrative for each asset and overall medical strategy
Lead and manage the execution of publication and congress planning, with an understanding of how these activities support the overall Medical Affairs and Brand strategy
Support the development of medical/scientific content for scientific exchange, medical affairs booths, advisory boards, and training
Manage external vendors/medical agencies assisting with medical content planning and execution and managing budgets
Manage the publication committee review and approval process and the review and approval of field medical content/materials as governed by the Medical, Legal Compliance, Regulatory (MLR) process
Ensure the delivery of high-quality, fair-balanced, scientifically/clinically accurate medical communications deliverables in accordance with established timelines, compliance guidelines/policies, and budgets
Support the creation of annual and long-range global medical communications plans and budgets
Qualification
Required
Doctoral level degree (Ph.D., Pharm.D., or M.D./D.O.) in life sciences with minimum of 12 years bio-pharmaceutical industry experience within Medical or Clinical Affairs
Experience with publication planning and execution as well as broader medical communications activities within the pharmaceutical or biotechnology industries
Excellent written and verbal communication skills, with the ability to understand and effectively communicate complex scientific and clinical data to internal and external stakeholders
Expertise in terms of clinical trial design, interpretation of scientific data, and communication
Demonstrated ability to successfully communicate complex concepts and data to a variety of audiences
Able to work independently and cross-functionally, with strong leadership skills, and effectively manage projects
Strategic and analytical thinker with the ability to plan and design effective publication and scientific communication strategies
Highly organized and detail oriented with the ability to manage multiple projects simultaneously, think critically, and adhere to tight deadlines
Strong program and project management skills with proven ability to drive key projects with minimal direction and oversight
Experience managing external vendors/medical agencies
Demonstrated functional knowledge of applicable guidelines including ICMJE, ACCME, OIG, PhRMA, GPP & GCP
Preferred
Experience with oncology or immuno-oncology products strongly preferred
HEOR experience strongly preferred
Company
Coherus Oncology
Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.27BKey Investors
Pharmakon AdvisorsNorthern Star PartnersShanghai Junshi Biosciences
2023-05-15Post Ipo Equity· $50M
2022-01-07Post Ipo Debt· $100M
2022-01-01Post Ipo Debt· $400M
Leadership Team
Dennis Lanfear
Founder, President, and Chief Executive Officer
Richard Hameister
Chief Technical Officer
Recent News
2026-01-06
2026-01-05
Company data provided by crunchbase